Interferon-Driven Immune Dysregulation in Down Syndrome: A Review of the Evidence
Open Access
- 1 October 2021
- journal article
- review article
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 14, 5187-5200
Abstract
Down syndrome (DS) is a unique genetic disease caused by the presence of an extra copy of chromosome 21, which carries four of the six interferon receptor (IFN-R) genes on its long arm. Recent studies reporting higher levels of interferon-stimulated gene (ISG) expression in primary immune cells studied ex vivo have suggested that the additional copies of the IFN-R genes in DS result in mild interferonopathy. In this review, we analyze the potential clinical and immunological impacts of this interferonopathy in DS. We performed a literature review to explore the epidemiology and risks of celiac disease, type 1 diabetes, thyroid dysfunction, mucocutaneous manifestations, infectious diseases (including COVID-19), and Alzheimer’s disease in individuals with DS relative to the general population with or without iatrogenic exposure to interferons. We analyzed immunophenotyping data and the current experimental evidence concerning IFN-R expression, constitutive JAK-STAT activation, and ISG overexpression in DS. Despite the lack of direct evidence that implicating this mild interferonopathy directly in illnesses in individuals with DS, we highlight the challenges ahead and directions that could be taken to determine more clearly the biological impact of interferonopathy on various immune-related conditions in DS.Keywords
This publication has 145 references indexed in Scilit:
- ACG Clinical Guidelines: Diagnosis and Management of Celiac DiseaseAmerican Journal of Gastroenterology, 2013
- Constitutive Type I Interferon Modulates Homeostatic Balance through Tonic SignalingImmunity, 2012
- Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasisJournal of Experimental Medicine, 2011
- Genomic views of STAT function in CD4+ T helper cell differentiationNature Reviews Immunology, 2011
- Infections and immunodeficiency in Down syndromeClinical and Experimental Immunology, 2011
- Inflammatory Bowel Disease and Mutations Affecting the Interleukin-10 ReceptorNew England Journal of Medicine, 2009
- Intrinsic defect of the immune system in children with Down syndrome: a reviewClinical and Experimental Immunology, 2009
- Complementation of a pathogenic IFNGR2 misfolding mutation with modifiers of N-glycosylationJournal of Experimental Medicine, 2008
- Natural Gene-Expression Variation in Down Syndrome Modulates the Outcome of Gene-Dosage ImbalanceThe American Journal of Human Genetics, 2007
- UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activityThe EMBO Journal, 2006